Related Experiment Video
Updated: Mar 13, 2026
09:32
Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
7.7K
Dermatologic uses of omalizumabtitle
Justin C Chia1, P Régine Mydlarski1
1a Division of Dermatology, Department of Medicine , University of Calgary , Calgary , Alberta , Canada.
The Journal of Dermatological Treatment
|November 8, 2016
Summary
Omalizumab, an anti-immunoglobulin E therapy, shows significant efficacy and safety in treating various recalcitrant dermatologic conditions, including chronic spontaneous urticaria. Further research is needed to confirm its long-term role in dermatology.
Area of Science:
- Immunodermatology
- Allergy and Immunology
- Pharmacology
Background:
- Omalizumab targets immunoglobulin E (IgE), a key mediator in allergic and autoimmune responses.
- While approved for asthma, its potential in dermatologic diseases is increasingly recognized.
- Understanding the mechanism of action is crucial for its expanding therapeutic applications.
Purpose of the Study:
- To review the existing literature on omalizumab's use in dermatology.
- To evaluate the safety and efficacy of omalizumab for various skin conditions.
- To discuss the mechanisms underlying omalizumab's therapeutic effects in dermatologic diseases.
Main Methods:
- Comprehensive literature search of PubMed, MEDLINE, and Embase databases (1990-2016).
- Inclusion of 99 articles reporting on omalizumab's dermatologic applications.
- Grading of evidence using the Oxford Centre for Evidence-Based Medicine criteria.
Main Results:
- Omalizumab demonstrated effectiveness across a spectrum of immune-mediated and autoimmune skin disorders.
- Specific conditions included chronic spontaneous urticaria, atopic dermatitis, and bullous pemphigoid.
- High efficacy was noted for chronic idiopathic urticaria (Grade A recommendation).
Conclusions:
- Omalizumab is a safe and effective treatment option for several challenging dermatologic conditions.
- Its utility extends to recalcitrant immune-mediated and autoimmune skin disorders.
- Further randomized clinical trials with long-term follow-up are recommended to solidify its dermatologic treatment role.
More Related Videos
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.2K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.2K
01:26Cholinergic Antagonists: Therapeutic Uses
1.6K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.6K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
693
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
693
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
636
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
636
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.4K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.4K
01:19Antiasthma Drugs: Leukotriene Modifiers
2.1K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.1K